Dr. Tanveer Abdul Majeed Medical Registration Verified
Surgical Oncologist
32 years of experience
Share your review for Dr. Tanveer Abdul Majeed
About Dr.Tanveer
Dr.Tanveer Specializations
- Surgical Oncologist
- Thoracic Oncologist
- Medical Oncologist
- Oncologist
- Bone Marrow Transplant Surgeon
Dr.Tanveer Education
- MBBS - Karnataka University, India
- MD - General Medicine - University of Mumbai, Mumbai
- DNB - General Medicine - University of Mumbai, Mumbai
- DNB - Surgical Oncology - University of Mumbai, Mumbai
Dr.Tanveer Experience
ConsultantS L Raheja Fortis Hospital
Dr.Tanveer Registration
- 75008 Maharashtra Medical Council 1994
Memberships
- Maharastra Medical Council
- National Academy of Medical Sciences - New Delhi
- Royal College of Physician & Surgeons (Glasgow)
- Royal College of Surgeon, Edinburgh
- Associations of surgeons of India
- Association of Colorectal Surgeons of India
- Indian Society of Oncology
- Indian Associations of Surgical Oncology
- Association of Minimally Access Invasive Surgeons of India (AMASI)
- International Hepato pancreaticobiliary Association
- Indian association of surgical Gastroenterologist
- Indian Cooperative Oncology Network
- Indian Society of Disease of Esophagus
Services
- Cancer Surgery
- Lung Cancer Treatment
- Cancer Treatment
- Oral Cancer Treatment
- Bone Marrow Transplant
Frequently Asked Questions (FAQ's) for Dr. Tanveer Abdul Majeed
What are Dr. Tanveer Abdul Majeed's qualifications?
What are the areas of expertise of Dr. Tanveer Abdul Majeed?
What types of treatment does Dr. Tanveer Abdul Majeed provide?
How many years of experience does Dr. Tanveer Abdul Majeed have?
Which hospitals/clinics does Dr. Tanveer Abdul Majeed visit?
Questions answered By Dr. Tanveer Abdul Majeed (1)
What is moderately differentiated squamous cell carcinoma lung? What are the treatment options?
Answered on 23rd May '24
Non small cell lung Cancer (NSCLC) is one form of Lung Cancer It is subdivided in to Adenocarcinoma and Squamous cell carcinoma
Lung cancer can be well differentiated , moderately differentiated or poorly differentiated depending on the microscopic pattern
NSCLC irrespective of being adeno or squamous has propensity for metatstases
Treatment options include for early stage Surgery ( Lobectomy or Pneumonectomy ) depending on stage and extent of disease, Intermediate stage lung cancer is treated with Neoadjuvant chemotherapy followed by Surgery or Radical chemo radiation depending on disease extent and Patient physiological condition There is an emerging role of Durvalumab in intermediate stage non resectable lesions
Advanced stage Patients are usually treated by palliative chemotherapy , targeted therapy and palliative care
Inspite of best of treatment, Lung cancer has dismal prognosis and the key to good outcome is early detection